2.5 mg in units tirzepatide dosing to 90 units of tirzepatide Semaglutide and Tirzepatide Dosage Charts: A Complete Guide 25 Mg Tirzepatide Dosing: Units

Importantly, tirzepatide is not recommended for use in patients with severe gastrointestinal disease, including severe gastroparesis

In Connecticut, look for a clinic that prioritizes medical oversight, safety, and long-term planning

Tirzepatide (22.5%) and Semaglutide (15%) are both FDA-approved and available today, with Tirzepatide showing superior results and better tolerability than Semaglutide

Our Services Medications Semaglutide Tirzepatide Wegovy Future Medications Upcoming FDA Approval triple G or Retatrutide (GLP, GIP, and CGRP injection) Orforglipron (oral GLP-1) CariSema (amylin and GLP-1 injection) MariTide (GLP-1 monthly injection) Nimacimab (MASH/MAFLD treatment) Non-Surgical Weight Loss Safe, effective alternatives to surgical weight loss Medically supervised programs tailored to your needs Personalized treatment plans using evidence-based methods Support for sustainable, long-term weight loss Nutrition & Weight Loss Guidance to improve daily food intake Strategies to balance blood sugar levels Support for building healthy eating habits Nutrition-focused plans to enhance overall health Weight Loss Management Ongoing support throughout your weight loss journey Adjustments to your medical weight loss program as needed Lifestyle coaching for sustainable results Tools to help you maintain your goal weight confidently Healthcare, the way you want it